AzTrials
AzTrials

Cerebrospinal; DisorderEC2NCT06350656

Study of Cerebral Compliance in Neurosurgical Intensive Care Units (EC2)

An observational study of Cerebrospinal; Disorder, run by Centre Hospitalier Universitaire de Saint Etienne at 7 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Despite the massive use of intracranial pressure in neuro-resuscitation, there is still no cerebral compliance evaluation index used in current practice to guide therapy. In treatment guidelines for intracranial hypertension, patients are placed in a prone position at about 30 degrees. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Cerebrospinal; Disorder
What is being tested?
Clinical data collection, Therapeutic data collection and IntraCranial Pression (ICP) values collection
How many people
30 participants
Where
7 sitesFrance
Study dates
31 Mar 2023to Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Sedated patient on mechanical ventilation with continuous intracranial pressure monitoring

Who may be able to join

  • Continuous intracranial pressure monitoring
  • Sedated patient on mechanical ventilation

Who cannot join

  • Craniectomy
  • Major hemodynamic failure

Trial locations and contacts

7 sites in 1 country.

7 sites in 1 country

France7 sites, 7 recruiting
  • CENTRE HOSPITALIER Charponnay

    Chaponnay, 69970

    PIERRE-HENRI MURGAT, MD

    Recruiting
  • CENTRE HOSPITALIER UNIVERSITAIRE Grenoble

    Grenoble, 38000

    JEAN FRANCOIS PAYEN, MD

    Recruiting
  • HOPITAL NORD La Tronche

    La Tronche, 38170

    KEVIN LAGARDE, MD

    Recruiting
  • APHP

    Paris, 75010

    SAMUEL GAUGUIN, MD

    Recruiting
  • Hopital Lariboisiere - Ahph

    Paris, 75010

    JEROME CARTAILLIER, MD

    Recruiting
  • CENTRE HOSPITALIER UNIVERSITAIRE Rennes

    Rennes, 35000

    YOANN LAUNEY, MD PHD

    Recruiting
  • CENTRE HOSPITALIER UNIVERSITAIRE Saint-Etienne

    Saint-Etienne, 42055

    CLEMENT MAGAND, MD

    Recruiting

Other trials in France

About this study

Despite the massive use of intracranial pressure in neuro-resuscitation, there is still no cerebral compliance evaluation index used in current practice to guide therapy.

In treatment guidelines for intracranial hypertension, patients are placed in a prone position at about 30 degrees. Several times a day, during nursing care, patients are flattened, which corresponds to a cerebral compliance test by adding a volume of cerebrospinal fluid to the cranial box.

Read the detailed description

This study aims to analyse the shape of the different components of the intracranial pressure waves (P1, P2, and P3) when the patient is flattened to determine an index to define the level of cerebral compliance.

Being tested
Clinical data collection, Therapeutic data collection, IntraCranial Pression (ICP) values collection
Keywords
Cerebrospinal compliance, Intracranial pressure., Head injury, Pulse waveform
Medical subject headings
Central Nervous System Diseases, Craniocerebral Trauma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Clinical data collectionOther

    Post-retrieval from the medical record

  • Therapeutic data collectionOther

    Post-retrieval from the medical record

  • IntraCranial Pression (ICP) values collectionOther

    Post-retrieval of ICP values from the monitor

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intracranial pressure (mmHg)

    Intracranial pressure is measured before (Raising the head by 30°) and during the flattening (Raising the head by 0°).

    Theses measures are done twice a day.

    The mean of theses values is calculated.

    Measured: Year : 1

Secondary outcomes (1)
  1. Correlation between ICP (Intra Cranial Pressure) doses and cerebral compliance

    Compare the ICP (Intra Cranial Pressure) dose value with the compliance index during the period before or after the flattening

    Measured: Year : 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2024
  2. Study start31 Mar 2023
  3. Primary completionApr 2024 (estimated)
  4. Study completionApr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06350656
Sponsor's protocol ID
IRBN282022/CHUSTE
Acronym
EC2
Status last verified
Apr 2024
First submitted
31 Mar 2023
Last updated
5 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cerebrospinal; Disorder, run by Centre Hospitalier Universitaire de Saint Etienne at 7 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact LAURENT GERGELE, MD ((0)477828593 ext. +33, laurent.gergele@chu-st-etienne.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intracranial pressure (mmHg) (time frame: Year : 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in